These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6956227)

  • 1. Metabolism and pharmacokinetics of aminophenazone in man of different age and under various pathological conditions.
    Werner M; Werner D
    Agents Actions Suppl; 1982; 10():99-107. PubMed ID: 6956227
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of radical species in the oxidation of aminopyrine and 4-aminoantipyrine by cumene hydroperoxide in rat liver microsomes.
    Ashley PL; Griffin BW
    Mol Pharmacol; 1981 Jan; 19(1):146-52. PubMed ID: 7207458
    [No Abstract]   [Full Text] [Related]  

  • 3. Further metabolism of 4-acetylaminoantipyrine, the major metabolite of aminopyrine, in rats.
    Tanaka T; Kaneo Y; Goromaru T; Iguchi S
    Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3519-22. PubMed ID: 3427730
    [No Abstract]   [Full Text] [Related]  

  • 4. [Main factors of variations in lidocaine pharmacokinetics].
    Bruguerolle B; Valli M; Jadot G; Bouyard P
    Therapie; 1983; 38(1):27-38. PubMed ID: 6346570
    [No Abstract]   [Full Text] [Related]  

  • 5. [Synthesis of aminoacyl derivatives of 4-aminoantipyrine. IV. Amino acid derivatives with D configuration].
    Kwapiszewski W; Kolwas J
    Acta Pol Pharm; 1984; 41(1):21-4. PubMed ID: 6496136
    [No Abstract]   [Full Text] [Related]  

  • 6. [Quantitative thin-layer chromatographic estimation of aminophenazone (I.N.N.), 4-methylaminophenazone and 4-aminophenazone in plasma (author's transl)].
    Hüller G; Haustein KO
    Pharmazie; 1981 Aug; 36(8):546-8. PubMed ID: 7291286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of caffeine in patients with decompensated type I and type II diabetes mellitus.
    Zysset T; Wietholtz H
    Eur J Clin Pharmacol; 1991; 41(5):449-52. PubMed ID: 1761072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone complication in diabetic subjects with good metabolic control and without any late complications: selected problems. Part I: calcium, phosphorus and magnesium metabolism].
    Zywiec J; Grzeszczak W; Pierzchała K
    Przegl Lek; 2001; 58(5):426-30. PubMed ID: 11603176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminopyrine metabolism in man: the acetylation of aminoantipyrine cosegregates with acetylation of caffeine.
    Agúndez JA; Carrillo JA; Martínez C; Benítez J
    Ther Drug Monit; 1995 Feb; 17(1):1-5. PubMed ID: 7725368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The current state of knowledge on age, sex, and their interactions on clinical pharmacology.
    Schwartz JB
    Clin Pharmacol Ther; 2007 Jul; 82(1):87-96. PubMed ID: 17495875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.
    Holstein A; Hammer C; Plaschke A; Ptak M; Kuhn J; Diekmann J; Kleesiek K; Egberts EH
    Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):429-34. PubMed ID: 15372362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic right heart insufficiency and drug metabolism. Research based on aminophenazone].
    Wagner K; Koppatz K; Günther KH; Schneider G
    Dtsch Gesundheitsw; 1971 Jul; 26(28):1303-5. PubMed ID: 5096983
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum nitric oxide metabolite (NO(x)) levels in hypertensive patients at rest: a comparison of age, gender, blood pressure and complications using normotensive controls.
    Higashino H; Miya H; Mukai H; Miya Y
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):725-31. PubMed ID: 17600548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [STUDIES ON THE OXIDATIVE DEGRADATION OF 4-AMINOPHENAZONE DERIVATIVES].
    PECHTOLD F
    Arzneimittelforschung; 1964 Apr; 14():258-9. PubMed ID: 14238565
    [No Abstract]   [Full Text] [Related]  

  • 15. Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes.
    Imagawa A; Hanafusa T; Iwahashi H; Uchigata Y; Kanatsuka A; Kawasaki E; Kobayashi T; Shimada A; Shimizu I; Maruyama T; Makino H
    Diabetes Res Clin Pract; 2008 Nov; 82(2):233-7. PubMed ID: 18789552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communications to the editor: A new metabolite of aminopyrine (aminophenazone) in man, 4-formylaminoantipyrine.
    Iguchi S; Goromaru T; Noda A
    Chem Pharm Bull (Tokyo); 1975 Apr; 23(4):932-4. PubMed ID: 1182870
    [No Abstract]   [Full Text] [Related]  

  • 17. The influence of renal function on the elimination kinetics of sulbenicillin in man.
    Montanari A; Borghi L; Canali M; Coruzzi P; Novarini A; Borghetti A
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):225-8. PubMed ID: 7390672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain amino acid abnormalities in kidney disease and diabetes mellitus.
    Schmidt P; Musshoff F; Hilgers C; Steins N; Bürrig KF; Jacob B; Daldrup T; Madea B
    Forensic Sci Int; 2004 Jun; 142(2-3):221-7. PubMed ID: 15172081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefapirin in patients with normal and impaired renal functions.
    Bergan T; Orjavik O; Brodwall EK
    Arzneimittelforschung; 1981; 31(10):1773-6. PubMed ID: 7198453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Insulin dependent (type 1) diabetes mellitus in advanced age].
    Halmos T; Suba I; Kautzky L
    Orv Hetil; 1998 Nov; 139(47):2829-31. PubMed ID: 9846062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.